- VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS
- VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE
- VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORS
- VALEO PHARMA REPORTS FIRST QUARTER 2024 RESULTS
- VALEO PHARMA TO HOST FIRST QUARTER 2024 RESULTS CONFERENCE CALL / WEBCAST
- VALEO PHARMA ANNOUNCES BOARD OF DIRECTORS CHANGES
- VALEO PHARMA AMENDS AGREEMENT WITH NOVARTIS PHARMACEUTICALS CANADA FOR (Pr)XIIDRA® IN CANADA AND CREDIT FACILITY WITH SAGARD HEALTHCARE ROYALTY PARTNERS, LP
- VALEO PHARMA REPORTS RECORD ANNUAL REVENUES FOR FISCAL YEAR 2023
More ▼
Key statistics
On Friday, Valeo Pharma Inc (VPH:TOR) closed at 0.115, 91.67% above the 52 week low of 0.06 set on Apr 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.095 |
---|---|
High | 0.115 |
Low | 0.095 |
Bid | 0.115 |
Offer | 0.12 |
Previous close | 0.095 |
Average volume | 183.09k |
---|---|
Shares outstanding | 98.68m |
Free float | 52.18m |
P/E (TTM) | -- |
Market cap | 11.35m CAD |
EPS (TTM) | -0.3255 CAD |
Data delayed at least 15 minutes, as of Apr 26 2024 21:00 BST.
More ▼